Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type of blood cancer. The ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.

It's easy to fall short on this mineral. Avoid trouble by getting more of these ample food sources of iron in your diet.

BAG3-associated dilated cardiomyopathy is a rare, inherited heart condition caused by mutations in the BAG3 gene, leading to early-onset, progressive heart failure due to impaired cardiac function, ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared. If approved as a test, doctors might detect cancers sooner and treat them ...

Scientists say they captured 3D images of a new organelle they're calling a "hemifusome," which may be a recycling center in ...